Sei Investments Co. Increases Stake in Alignment Healthcare, Inc. $ALHC

Sei Investments Co. lifted its position in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 66.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 739,063 shares of the company’s stock after acquiring an additional 295,634 shares during the quarter. Sei Investments Co.’s holdings in Alignment Healthcare were worth $13,022,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in Alignment Healthcare by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock worth $305,983,000 after acquiring an additional 1,524,218 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of Alignment Healthcare by 26.9% in the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after purchasing an additional 2,981,166 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Alignment Healthcare by 0.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after purchasing an additional 79,268 shares in the last quarter. Invesco Ltd. lifted its position in shares of Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock worth $122,501,000 after purchasing an additional 1,735,962 shares during the period. Finally, 8 Knots Management LLC lifted its position in shares of Alignment Healthcare by 6.4% in the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock worth $70,222,000 after purchasing an additional 300,409 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Trading Up 1.7%

NASDAQ:ALHC opened at $18.61 on Friday. The stock has a market capitalization of $3.85 billion, a price-to-earnings ratio of 206.78, a PEG ratio of 2.47 and a beta of 1.05. Alignment Healthcare, Inc. has a 52 week low of $12.91 and a 52 week high of $25.12. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56. The firm has a 50 day moving average of $19.73 and a 200 day moving average of $19.80.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the previous year, the company earned $0.07 earnings per share. The business’s revenue for the quarter was up 31.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Joseph S. Konowiecki sold 25,000 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total transaction of $600,000.00. Following the transaction, the executive vice president directly owned 1,103,816 shares of the company’s stock, valued at $26,491,584. This represents a 2.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark D. Kent purchased 14,848 shares of the stock in a transaction on Tuesday, June 2nd. The stock was acquired at an average cost of $13.31 per share, with a total value of $197,626.88. Following the acquisition, the insider owned 14,848 shares of the company’s stock, valued at approximately $197,626.88. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders sold 1,039,951 shares of company stock worth $19,976,967 over the last quarter. Company insiders own 5.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ALHC shares. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Barclays reduced their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Finally, Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Six investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average price target of $24.30.

Key Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Q2 earnings and revenue beat expectations: Alignment reported adjusted earnings of $0.17 per share, above the $0.13 consensus estimate and up from $0.07 a year earlier. Revenue reached $1.34 billion, exceeding the $1.31 billion estimate and rising 31.6% year over year. Alignment Healthcare Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Improved profitability: Second-quarter net income more than doubled to $36.6 million as medical-care costs for members in its Medicare Advantage plans eased. The company said it surpassed the high end of guidance across key metrics, supporting investor confidence in its cost-management efforts. Alignment Healthcare Turns Profit as Insurer Gets Handle on Costs
• Neutral Sentiment: Revenue outlook was broadly in line: Alignment guided to approximately $1.3 billion in third-quarter revenue and $5.2 billion for full-year 2026, matching consensus estimates. The provided guidance did not include usable EPS figures, limiting the market’s ability to assess the earnings outlook.
• Negative Sentiment: Investor investigations add risk: Kaplan Fox, Lowey Dannenberg and Pomerantz announced investigations into possible federal securities-law violations involving Alignment Healthcare. These announcements do not establish wrongdoing, but they may increase legal, financial and reputational uncertainty and weigh on the stock. Lowey Dannenberg Alignment Healthcare Investigation

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.